BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Authors

A. S. Hamy, I. Bieche, J. Lehmann-Che, V. Scott, Ph. Bertheau, J. M. Guinebretière, M. C. Matthieu, B. Sigal-Zafrani, O. Tembo, M. Marty, B. Asselain, F. Spyratos, P. de Cremoux